GRAIL is trading at $133.80, down 6.86% in pre-market after Q3 revenue missed consensus.

  • The November 4 release reported $37.5 million in Q3 revenue, below the $44.21 million consensus estimate, despite Galleri test volume growing about 24% year over year.
  • Galleri revenue grew 14%, while adjusted gross margin fell to 42% from 55% a year earlier.
  • Net loss widened to $103.6 million; earnings coverage cited lower pricing and the revenue shortfall as negatives.